Studies have shown IGF-IR levels are highly expressed in 39-93% of human breast cancers [9]and in breast tumors expressing high levels of IGF-IR the receptor is expressed 10-14-fold higher on average compared to normal breast tissue [10,11]. This evidence concerns the gene IGF1R and breast neoplasm.